medigraphic.com
SPANISH

CorSalud (Revista de Enfermedades Cardiovasculares)

ISSN 2078-7170 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 3

<< Back Next >>

CorSalud 2015; 7 (3)

Valve patch for the treatment of atrial septal defect in patients with severe pulmonary hypertension: A quasi-experimental study

Márquez-González H, Yáñez-Gutiérrez L, López-Gallegos D, Riera-Kinkel C
Full text How to cite this article

Language: Spanish
References: 14
Page: 195-201
PDF size: 309.35 Kb.


Key words:

atrial septal defect, surgery, valve patch, pulmonary arterial hypertension.

ABSTRACT

Introduction: Atrial septal defect detected in adulthood is associated with pulmonary arterial hypertension. The corrective surgical procedure in these conditions shows increased morbidity and mortality. The use of valve patch prevents the occurrence of early complications.
Objectives: To analyze the behavior of pulmonary pressure, estimated by echocardiography, and right ventricular function, at two years, in patients who underwent valve patch closure of atrial septal defect with severe pulmonary arterial hypertension.
Method: A quasi-experimental study was conducted in patients with atrial septal defect with bad edges and severe pulmonary arterial hypertension. Subjects with evidence of positive reactivity to oxygen or nitric oxide, who gave their informed consent, were included; and patients with genetic syndromes or primary pulmonary arterial hypertension were excluded. Patients were clinically followed up in the immediate postoperative period, through laboratory tests and echocardiography at 2, 4, 6, 12, 18 and 24 months after surgery. And complications were recorded.
Results: There was no early or late death in the 12 patients analyzed. Median mechanical ventilation was 2 (1-4) days. The follow up showed a significant improvement in functional class, echocardiographic variables and medication intake.
Conclusions: Unidirectional valve patch is a therapeutic option that avoids postoperative complications which are the cause of early mortality.


REFERENCES

  1. Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet C Semin Med Genet. 2004;125:12-21.

  2. Turner SW, Hunter S, Wyllie JP. The natural history of ventricular septal defects. Arch Dis Child. 1999; 81:413-6.

  3. Attie F. Comunicación interauricular en pacientes mayores de 40 años. Rev Esp Cardiol. 2002;55:S33- 6.

  4. Talwar S, Choudhary SK, Saxena A, Kothari SS, Juneja R, Airan B. Unidirectional valved patches for closure of septal defects in patients with severe pulmonary hypertension. Ann Pediatr Cardiol. 2008;1: 114-9.

  5. Novick WM, Gurbuz AT, Watson DC, Lazorishinets W, Perepeka AN, Malcic I, et al. Double patch closure of ventricular septal defect with increased pulmonary vascular resistance. Ann Thorac Surg. 1998; 66:1533-8.

  6. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53:1573-619.

  7. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981;64:1227-34.

  8. Kowalik E, Kowalski M, Hoffman P. Is right ventricular myocardial deformation affected by degree of interatrial shunt in adults? Eur J Echocardiogr. 2011;12:400-5.

  9. Adatia I, Beghetti M. Early postoperative care of patients with pulmonary hypertension associated with congenital cardiac disease. Cardiol Young. 2009;19:315-9.

  10. Viswanathan S, Kumar RK. Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance. Catheter Cardiovasc Interv. 2008;71:665-70.

  11. Lopes AA, O'Leary PW. Measurement, interpretation and use of haemodynamic parameters in pulmonary hypertension associated with congenital cardiac disease. Cardiol Young. 2009;19:431-5.

  12. Novick WM, Sandoval N, Lazorhysynets VV, Castillo V, Baskevitch A, Mo X, et al. Flap valve double patch closure of ventricular septal defects in children with increased pulmonary vascular resistance. Ann Thorac Surg. 2005;79:21-8.

  13. Rao PS, Raju V, Narayana M. Flap valved closure of ventricular septal defects with increased pulmonary vascular resistance. Interact Cardiovasc Thorac Surg. 2010;11:577-80.

  14. Cho YH, Jun TG, Yang JH, Park PW, Huh J, Kang IS, et al. Surgical strategy in patients with atrial septal defect and severe pulmonary hypertension. Heart Surg Forum. 2012;15:E111-5.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

CorSalud. 2015;7